Your browser doesn't support javascript.
loading
FOX(M1) news--it is cancer.
Halasi, Marianna; Gartel, Andrei L.
Afiliación
  • Halasi M; University of Illinois at Chicago, Department of Medicine, Chicago, IL 60612, USA.
Mol Cancer Ther ; 12(3): 245-54, 2013 Mar.
Article en En | MEDLINE | ID: mdl-23443798
ABSTRACT
FOXM1 is an oncogenic transcription factor of the Forkhead family and it has a well-defined role in cell proliferation and cell-cycle progression. Expression of FOXM1 is excluded in quiescent or differentiated cells, but its level is highly elevated in proliferating and malignant cells. Overexpression of FOXM1 has been reported in more than 20 types of human cancer. In recent years, FOXM1 has been implicated in diverse cellular processes and also a growing body of experimental data has underlined the relevance of FOXM1 in tumorigenesis. Although FOXM1 is under the control of three major tumor suppressors (RB, p53, and p19(ARF)), it is still active in the majority of human cancers. The oncogenic potential of FOXM1 is mainly based on its ability to transcriptionally activate genes that are involved in different facets of cancer development. In this review, the contribution of FOXM1 to each of the hallmarks of cancer will be summarized and discussed.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Activación Transcripcional / Transformación Celular Neoplásica / Factores de Transcripción Forkhead / Neoplasias Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Activación Transcripcional / Transformación Celular Neoplásica / Factores de Transcripción Forkhead / Neoplasias Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos